Home/Filings/4/0001209191-22-058892
4//SEC Filing

Guttman-McCabe Christopher 4

Accession 0001209191-22-058892

CIK 0001304492other

Filed

Nov 27, 7:00 PM ET

Accepted

Nov 28, 7:19 PM ET

Size

5.3 KB

Accession

0001209191-22-058892

Insider Transaction Report

Form 4
Period: 2022-11-25
Guttman-McCabe Christopher
Chief Reg & Comm Officer
Transactions
  • Sale

    Common Stock

    2022-11-25$36.20/sh8,332$301,66054,352 total
Footnotes (1)
  • [F1]This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $35.93 to $36.64. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Issuer

Anterix Inc.

CIK 0001304492

Entity typeother

Related Parties

1
  • filerCIK 0001828490

Filing Metadata

Form type
4
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 7:19 PM ET
Size
5.3 KB